SNOA News and Press, Sonoma Pharmaceuticals Inc. From 10/07/25

BOULDER, COLORADO / ACCESS Newswire / October 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology-based stabilized hypochlorous acid (HOCl) products, today announced that it has successfully registered i...

BOULDER, COLORADO / ACCESS Newswire / September 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound car...

BOULDER, CO / ACCESS Newswire / August 26, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye ...

A look at the top 10 most actives in the United States TPI Composites Inc. (TPIC) rose 89.9% to $0.2963 on volume of 646,640,621 shares Expion360 Inc. (XPON) rose 54.2% to $2.02 on volume of 386,292,409 shares Opendoor Technologies Inc (OPEN) rose 25.6% to $3.04 on volume of 316,110,575 sha...

2025-08-14 10:13:10 ET Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) is one of today’s top gainers. The company’s shares have moved 1.73% on the day to $3.05. Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care,...

2025-08-14 10:10:08 ET DENVER, Colo., Aug 14, 2025 ( 247marketnews.com )- Markets are waking up to a flurry of action in the small and mid-cap space as Thursday morning kicks off with pre-market surges, biotech momentum, and institutional tailwinds in entertainment infrastructure. ...

A look at the top 10 most actives in the United States Expion360 Inc. (XPON) rose 201.5% to $3.9503 on volume of 172,642,808 shares TeraWulf Inc. (WULF) rose 34.1% to $7.32 on volume of 86,132,185 shares Aeries Technology Inc. (AERT) rose 55.7% to $1.0899 on volume of 66,941,242 shares So...

BOULDER, CO / ACCESS Newswire / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn ® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye,...

Revenues increased 18% compared to same period last year U.S. revenue increased 57% compared to same period last year Net loss per share decreased 43% compared to same period last year BOULDER, COLORADO / ACCESS Newswire / August 7, 2025 / Sonoma Pharmaceuticals, Inc. (Nas...

2025-06-17 16:13:19 ET More on Sonoma Pharmaceuticals Financial information for Sonoma Pharmaceuticals Read the full article on Seeking Alpha For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $3.75M